Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|5|549-558

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.5, 2015-09, pp. : 549-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pericarditis during infliximab therapy in paediatric ulcerative colitis

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 107-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

PET/MRI for evaluating subclinical inflammation of ulcerative colitis

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 47, Iss. 3, 2018-03 ,pp. : 737-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 603-612

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 4, 2015-04 ,pp. : 412-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 979-979

John Wiley & Sons Inc

Access to resources Recommend Favorite